TWM478483U - Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer - Google Patents
Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer Download PDFInfo
- Publication number
- TWM478483U TWM478483U TW102220976U TW102220976U TWM478483U TW M478483 U TWM478483 U TW M478483U TW 102220976 U TW102220976 U TW 102220976U TW 102220976 U TW102220976 U TW 102220976U TW M478483 U TWM478483 U TW M478483U
- Authority
- TW
- Taiwan
- Prior art keywords
- capsule
- colorectal cancer
- protective layer
- capsule structure
- core
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Description
本創作係關於一種可包埋粉末之膠囊結構的技術領域。This creation relates to the technical field of a capsule structure that can embed powder.
牛樟芝(Antrodia camphorata),又稱樟芝或牛樟菇等,於分類學上屬於真菌界(Fungi)、擔子菌門(Basidiomycota)、擔子菌亞門(Basidiomycotina)、同擔子菌綱(Homobasidiomycetes)、無褶菌目(Aphyllophorales)、多孔菌科(Polyporaceae)、薄孔菌屬(Antrodia)。牛樟芝子實體生長於台灣保育類牛樟樹(Cirnamoum kanehirai Hay)之心材內壁,週邊向內彎曲,能分解木材之纖維素而造成木頭腐朽,為木頭腐朽菌。野生牛樟芝生長環境均屬於幽暗、潮濕且溫度較低之中海拔地區,特別是野生牛樟芝生長緩慢,因此產生子實體需要相當長的時間。由於牛樟樹為保育類樹種且分布數量極為稀少,再加上人為的盜採,使得野生牛樟芝數量相當稀少,使得牛樟芝價格昂貴,所以具有「森林中的紅寶石」之美稱。Antrodia camphorata, also known as Antrodia camphorata or Burdock mushroom, belongs to the fungi community (Fungi), Basidiomycota, Basidiomycotina, Homobasidiomycetes, and taxonomy. Aphyllophorales, Polyporaceae, Antrodia. The body of the burdock is grown on the inner wall of the heartwood of Taiwan's conservation burdock (Cirnamoum kanehirai Hay). The periphery is curved inward and can decompose the cellulose of the wood and cause the wood to decay. It is a decaying wood. The growth environment of wild Antrodia camphorata belongs to the dark, humid and low temperature middle altitude areas, especially the wild Antrodia camphora grows slowly, so it takes a long time to produce fruiting bodies. Because burdock is a kind of conservation tree species and the distribution is extremely rare, coupled with artificial piracy, the number of wild burdock is quite rare, making the burdock an expensive price, so it has the reputation of "the ruby in the forest".
牛樟芝子實體為多年生,無柄且為木栓質至木質,具有濃厚的樟樹香氣,形態多變,有板狀、鐘狀、馬蹄狀或塔狀,緊貼於木材表面,菇體表面孔狀,初生時鮮紅色,隨著生長逐變為乳白色、淡紅褐色、淡褐色或淡黃褐色,週邊常呈放射狀,並往四週擴展生長,呈半圓狀或不規則 形。The body of Ox sylvestris is perennial, sessile and cork-to-wood. It has a strong aroma of eucalyptus and has a variety of shapes. It has a plate shape, a bell shape, a horseshoe shape or a tower shape. It is close to the surface of the wood and has a pore shape on the surface of the mushroom. It is bright red at birth, and becomes milky white, reddish brown, light brown or yellowish brown with growth. The periphery is often radial and grows to the periphery, showing a semicircular or irregular shape. shape.
有些牛樟芝的種類被發現具有藥理活性,在台灣民俗醫學療法上,牛樟芝子實體被認為具有某些醫藥功效,將該子實體細磨成乾燥粉末或以熬煮方式口服,為民間流傳具療效的食藥菇類,具有解毒、抗發炎、抗腫瘤、抑制血管增生及治療肝臟疾病等活性。Some species of Antrodia camphorata have been found to have pharmacological activity. In Taiwan folk medicine therapy, the body of A. sylvestris is considered to have certain medical effects. The fruiting body is finely ground into a dry powder or taken orally in a boiled way, which is effective for folk circulation. The edible mushroom has the activities of detoxification, anti-inflammatory, anti-tumor, inhibition of vascular proliferation and treatment of liver diseases.
大腸(large intestine)包括盲腸、結腸和直腸三大段,其係為人體消化系統之最末段關卡。正常之大腸黏膜會因許多因素使良性細胞於大腸內壁增生而形成腺瘤(即瘜肉),甚至進一步成為大腸癌(colorectal cancer)。大腸癌亦可通稱為結腸直腸癌等,其係為世界上最普遍的惡性腫瘤之一,近年來在台灣地區,由於國人生活及飲食方式之西化與精緻化,以及動物性脂肪與蛋白質攝取量的逐年增加,且食物纖維攝取的日益減少,使得大腸癌罹患率逐年攀升,如今已成為癌症死亡原因中第三位。The large intestine consists of the cecum, colon and rectum, which are the last level of the human digestive system. Normal colorectal mucosa can cause benign tumors (ie, sputum) to proliferate in the inner wall of the large intestine due to many factors, and even further become colorectal cancer. Colorectal cancer, also known as colorectal cancer, is one of the most common malignant tumors in the world. In recent years, in Taiwan, due to the westernization and refinement of Chinese people's living and eating patterns, and animal fat and protein intake. The year-on-year increase and the diminishing consumption of dietary fiber have led to an increase in the incidence of colorectal cancer, which is now the third leading cause of cancer death.
大腸癌之主要症狀包括血便、通便異常、腹漲感、貧血甚至觸摸到腹部硬塊等。大腸癌早期發生時不易有自覺症狀,但當自覺有前列症狀時,都已非早期癌的階段,造成治療上的困難度。此外,大腸癌一般發生在五十歲以上的患者,但研究指出台灣地區之大腸癌患者的平均年齡比外國低,年輕化趨勢明顯,且年輕人得到大腸癌的預後都比較差,這和年輕人的癌症通常是分化較差、惡性度較高的癌症有關係,同時,亦由於年輕人的癌症常為初次診斷時已經是末期癌症有關。The main symptoms of colorectal cancer include bloody stools, abnormal bowel movements, abdominal sensation, anemia, and even touching the abdominal lumps. Colorectal cancer is not easy to have symptoms when it occurs early, but when it has conscious symptoms, it is already a stage of non-early cancer, which causes difficulty in treatment. In addition, colorectal cancer generally occurs in patients over the age of 50, but studies have shown that the average age of colorectal cancer patients in Taiwan is lower than that of foreign countries, the trend of rejuvenation is obvious, and the prognosis of young people with colorectal cancer is relatively poor, this and young. Human cancer is usually associated with poorly differentiated, highly malignant cancers, and because young people's cancers are often associated with terminal cancer at the time of initial diagnosis.
大腸癌的治療方法主要以外科手術切除為主,對於癌細胞擴散的患者,則輔以放射治療和化學治療。化學治療的主要作用之一是干擾癌細胞週期的進行,影響其DNA、RNA和蛋白質的合成,達到抑制腫瘤細 胞增殖之目的,然而放射治療和化學治療往往會伴隨其他引起身體不適之副作用的產生;另一方面,肝臟以及肺臟是大腸癌最容易產生遠端轉移的部位,大腸癌一旦發生遠端轉移,即便進行複合式化學治療及癌細胞標靶治療,對多數的遠端轉移病患之成效有限,且其預後狀況不佳。因此開發有效且副作用小的治療物質以供臨床應用係為勢在必行。The treatment of colorectal cancer is mainly based on surgical resection, and for patients with cancer cell proliferation, radiation therapy and chemotherapy are supplemented. One of the main effects of chemotherapy is to interfere with the progression of cancer cells, affecting the synthesis of DNA, RNA and proteins, and inhibiting tumors. For the purpose of cell proliferation, however, radiation therapy and chemotherapy are often accompanied by other side effects that cause physical discomfort; on the other hand, liver and lung are the sites most likely to produce distant metastasis of colorectal cancer. Even with combined chemotherapy and cancer cell target therapy, the results of most patients with distant metastases are limited and their prognosis is poor. Therefore, it is imperative to develop therapeutic substances with effective and low side effects for clinical application.
目前諸多之實驗可得知牛樟芝子實體具有抗癌功效,且其所含成分亦陸續被分析出。因此,若能提供該等患者一更佳之治療或預防大腸癌之方法,是一迫切亟需解決之課題。At present, many experiments have revealed that the body of A. angustifolia has anti-cancer effect, and its components are also analyzed. Therefore, it would be an urgent problem to provide a better treatment for these patients or to prevent colorectal cancer.
由此,本案創作人鑑於上述衍生之缺失,乃亟思加以改良創新,除了研發一牛樟芝粉末,其中之活性成分具有抑制大腸癌腫瘤細胞生長及擴散之效用;此外,搭配本創作之膠囊結構,可供使用者易於攝取足夠之牛樟芝粉末,並藉此治療、或預防大腸癌。是故,提出本件『一種抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構』。Therefore, in view of the above-mentioned lack of the above-mentioned derivatives, the creators of this case have improved and innovated, in addition to the development of a burdock powder, the active ingredient of which has the effect of inhibiting the growth and spread of colorectal cancer cells; in addition, with the capsule structure of the present invention, It is easy for the user to ingest enough of the Antrodia camphorata powder to treat or prevent colorectal cancer. Therefore, this article proposes a structure of a capsule of Astragalus membranaceus that inhibits the growth and spread of colorectal cancer cells.
本創作之目的即在於提供一種抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構。The purpose of the present invention is to provide a capsule structure of Antrodia camphorata powder which inhibits the growth and spread of colorectal cancer tumor cells.
本創作之次一目的在於提供一種膠囊結構,以使其中之牛樟芝粉末之活性成分得以於服用者體內發揮其抑制大腸癌腫瘤細胞生長及擴散之效用。A second object of the present invention is to provide a capsule structure in which the active ingredient of the Antrodia camphorata powder can exert its effect on inhibiting the growth and spread of colorectal cancer tumor cells in a user.
可達成上述創作目的之一種抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構,包括:一囊殼、一保護層、及一核心;該核心 係被該保護層所披覆,該保護層再以一囊殼包覆之。A capsule structure for inhibiting the growth and spread of colorectal cancer tumor cells, comprising: a capsule, a protective layer, and a core; It is covered by the protective layer, which is then covered with a capsule.
本創作所提供之牛樟芝粉末膠囊結構,除了可供內含之牛樟芝粉末(及其活性成分)得以被長時間保存外;此外,其核心所含之牛樟芝粉末(及其活性成分)亦可抑制大腸癌腫瘤細胞生長及擴散。本創作提供之膠囊結構可易於使使用者服用,因此,除可用於日常保健外,亦可搭配其他療程一併使用之。The structure of the Antrodia camphorata powder capsule provided by the present invention can be preserved for a long time in addition to the contained Antrodia camphorata powder (and its active ingredient); in addition, the core of the Antrodia camphorata powder (and its active ingredient) can also inhibit the large intestine Cancer tumor cell growth and spread. The capsule structure provided by this creation can be easily taken by the user, so that it can be used in combination with other treatments in addition to daily health care.
1‧‧‧膠囊結構1‧‧‧Capsule structure
11‧‧‧囊殼11‧‧‧ capsule
12‧‧‧保護層12‧‧‧Protective layer
13‧‧‧核心13‧‧‧ core
圖一為一種抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構的剖面圖。Figure 1 is a cross-sectional view showing the structure of an Antrodia camphorata powder capsule which inhibits the growth and spread of colorectal cancer tumor cells.
本創作係提供一種抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構,根據本創作詳細說明之,並請參閱第一圖說明。The present invention provides a structure of an Antrodia camphorata powder capsule which inhibits the growth and spread of colorectal cancer tumor cells, and is described in detail according to the present creation, and is referred to the first figure.
本創作之抑制大腸癌腫瘤細胞生長及擴散之牛樟芝粉末膠囊結構1,由外至內依序包括:一囊殼11、一保護層12、及一核心13;該核心13係被該保護層12所披覆,除了可用以阻隔外界環境與該核心13之間的氧化作用外,亦可用以保護核心13中之牛樟芝活性成分不受胃酸等因素所破壞。另,該保護層12再以一囊殼11包覆,以保護核心13及保護層12免於受物理性因子(如:重壓、尖刺等)之破壞。The present invention comprises a structure 1 for the growth and spread of colorectal cancer tumor cells, which comprises, in order from the outside to the inside, a capsule 11, a protective layer 12, and a core 13; the core 13 is protected by the protective layer 12 The coating, in addition to blocking the oxidation between the external environment and the core 13, can also be used to protect the active constituents of the Antrodia camphorata in the core 13 from being damaged by factors such as gastric acid. In addition, the protective layer 12 is further covered by a capsule 11 to protect the core 13 and the protective layer 12 from physical factors such as heavy pressure, spikes, and the like.
其中該囊殼11所用之成分包含但不限於:明膠(吉利丁(Gelatin))、甲基纖維素(Methyl cellulose)、羥丙基甲基纖維素(Hydroxymethyl propyl cellulose)、羥丙基纖維素(Hydroxymethyl propyl cellulose)、聚乙烯醇(Polyvinyl alcohol)、聚乙烯吡咯酮(Polyvinyl pyrrolidone)、鄰苯二甲酸醋酸纖維素(Cellulose acetate phthalate)、鄰苯二甲酸羥丙基纖維素(Hydroxypropyl methylcellulose phthalate)或其它適用於本創作的材料;其中該明膠可包含動物性明膠(由魚皮、豬皮等動物性來源所製成)及植物性明膠(如:羥丙基甲基纖維素(HPMC))。The components used in the capsule 11 include, but are not limited to, gelatin (Gelatin), methyl cellulose (Methyl cellulose), and hydroxypropyl methyl cellulose (Hydroxymethyl). Propyl cellulose), Hydroxymethyl propyl cellulose, Polyvinyl alcohol, Polyvinyl pyrrolidone, Cellulose acetate phthalate, Hydroxy phthalate Hydroxypropyl methylcellulose phthalate or other materials suitable for the present invention; wherein the gelatin may comprise animal gelatin (made from animal sources such as fish skin, pig skin, etc.) and vegetable gelatin (eg, hydroxypropyl) Methyl cellulose (HPMC)).
其中該保護層12之可包含但不限於:賦形劑、崩解劑、腸溶衣、黏合劑、稀釋劑、包覆劑、潤脹劑、潤滑劑、調味劑、甜味劑、增溶劑、或其之任意組合。The protective layer 12 may include, but is not limited to, an excipient, a disintegrant, an enteric coating, a binder, a diluent, a coating agent, a swelling agent, a lubricant, a flavoring agent, a sweetener, a solubilizing agent. Or any combination thereof.
其中,如賦形劑可為糖類,包括乳糖、蔗糖、甘露醇、山梨醇;纖維素製備物像是,例如,玉米澱粉、小麥澱粉、稻米澱粉、馬鈴薯澱粉、明膠、黃蓍膠等或其他適用本創作之材料;其可用以增加口感、支撐整體之結構、及保護核心13。Wherein, the excipient may be a sugar, including lactose, sucrose, mannitol, sorbitol; the cellulose preparation is, for example, corn starch, wheat starch, rice starch, potato starch, gelatin, tragacanth, etc. or other Materials suitable for this creation; they can be used to increase the mouthfeel, support the overall structure, and protect the core 13.
其中該核心13中包含牛樟芝粉末(活性物質),其可用以抑制大腸癌腫瘤細胞生長及擴散。該牛樟芝粉末可從牛樟芝子實體中製成。The core 13 contains an Antrodia camphorata powder (active substance) which can be used to inhibit the growth and spread of colorectal cancer tumor cells. The Antrodia camphorata powder can be made from the fruit body of Antrodia camphorata.
上述膠囊結構1亦可視需要適宜地添加一或多種以上該領域通常會使用的保存劑、著色劑、香料及風味劑或其它適用於本創作的添加物,以使其賦形、保存、上色、增添風味。The above-mentioned capsule structure 1 may also be suitably added with one or more kinds of preservatives, colorants, flavors and flavors or other additives suitable for the present invention which are commonly used in the field, so as to shape, preserve and color. Add flavor.
上述粉末膠囊結構可藉由製備於膠囊內以供口服外,亦可直接服用、或藉由其他適用本創作之形式服用。The above powder capsule structure can be prepared by taking it in a capsule for oral administration, or by taking it directly or by other forms suitable for the present invention.
上列詳細說明係針對本創作之一可行實施方式之具體說明,惟該實施例並非用以限制本創作之專利範圍,凡未脫離本創作技藝精 神所為之等效實施或變更,均應包含於本案之專利範圍中。The detailed description above is a detailed description of one of the possible implementations of the present invention, but the embodiment is not intended to limit the scope of the patent of the present invention. The equivalent implementation or change of God shall be included in the scope of the patent in this case.
綜上所述,本案所揭露之技術特徵已充分符合新穎性、進步性及產業利用性之法定專利要件,爰依法提出申請,懇請 貴局核准本件新型專利申請案,以勵發明,至感德便。In summary, the technical features disclosed in this case have fully met the statutory patent requirements for novelty, advancement and industrial applicability. If you apply in accordance with the law, you are requested to approve the new patent application for your invention. Will.
1‧‧‧膠囊結構1‧‧‧Capsule structure
11‧‧‧囊殼11‧‧‧ capsule
12‧‧‧保護層12‧‧‧Protective layer
13‧‧‧核心13‧‧‧ core
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102220976U TWM478483U (en) | 2013-11-08 | 2013-11-08 | Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102220976U TWM478483U (en) | 2013-11-08 | 2013-11-08 | Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM478483U true TWM478483U (en) | 2014-05-21 |
Family
ID=51295857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102220976U TWM478483U (en) | 2013-11-08 | 2013-11-08 | Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM478483U (en) |
-
2013
- 2013-11-08 TW TW102220976U patent/TWM478483U/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burk | Puffball usages among North American indians | |
TWM478454U (en) | Antrodia cinnamomea powder capsule structure for inhibiting gastric cancer tumor cell proliferation and metastasis | |
TWM478483U (en) | Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of colorectal cancer | |
CN109718252A (en) | American-cockroach-extract treats and prevents the application in chemotherapy cause intestinal mucosa inflammation drug in preparation | |
TWM481014U (en) | Antrodia cinnamomea powder capsule structure for the treatment of tumor cells | |
TWM478453U (en) | Antrodia cinnamomea powder capsule structure for inhibiting esophageal cancer tumor cell proliferation and metastasis | |
TWM478455U (en) | Antrodia cinnamomea powder capsule structure for inhibiting lung cancer tumor cell proliferation and metastasis | |
TWM478452U (en) | Antrodia cinnamomea powder capsule structure for inhibiting bone cancer tumor cell proliferation and metastasis | |
TWM478471U (en) | Embedding structure of Antrodia cinnamomea particle for improve gastrointestinal disease | |
TWM485048U (en) | Antrodia cinnamomea powder capsule structure having anticancer and antioxidation functions | |
TWM478493U (en) | Antrodia camphorata powder capsule structure for suppressing growth and metastasis of tumor cells of oral cancer | |
TWM478488U (en) | Antrodia camphorate powder capsule structure for suppressing growth and propagation of tumor cells of nasopharyngeal cancer | |
TWM478447U (en) | Antrodia cinnamomea powder capsule structure having assisting anticancer drug | |
TWM478490U (en) | Antrodia camphorata powder capsule structure for suppressing growth and metastasis of tumor cells of brain cancer | |
TWM478484U (en) | Antrodia camphorata powder capsule structure for suppressing growth and metastasis of tumor cells of liver cancer | |
TWM481015U (en) | Antrodia cinnamomea powder capsule structure for inhibiting cancer cell proliferation | |
TWM478489U (en) | Antrodia cinnamomea powder capsule structure for suppressing hepatitis B virus | |
TWM478485U (en) | Antrodia camphorate powder capsule structure for inducing reversion and apoptosis of cancer cells | |
TWM478492U (en) | Antrodia cinnamomea powder capsule structure for suppressing growth and proliferation of tumor cells of skin cancer | |
TWM478446U (en) | Antrodia cinnamomea powder capsule structure for inhibiting angiogenesis action mechanism | |
TWM478486U (en) | Antrodia cinnamomea powder capsule structure featuring anti-inflammation and anti-tumor activity | |
TWM478451U (en) | Antrodia cinnamomea powder capsule structure for inhibiting lymphoma tumor cell proliferation and metastasis | |
TWM522731U (en) | Composite tablet structure with stout camphor carrier | |
TWM478450U (en) | Phellinus linteus particle embedding structure for inhibiting colorectal cancer cell proliferation and metastasis | |
TWM478494U (en) | Antrodia camphorate powder capsule structure for suppressing growth and propagation of tumor cells of pancreatic cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4K | Annulment or lapse of a utility model due to non-payment of fees |